These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23772504)

  • 21. Sleep duration, obesity and insulin resistance in a multi-ethnic UK population at high risk of diabetes.
    Brady EM; Bodicoat DH; Hall AP; Khunti K; Yates T; Edwardson C; Davies MJ
    Diabetes Res Clin Pract; 2018 May; 139():195-202. PubMed ID: 29526681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Type 2 diabetes and impaired glucose tolerance].
    Furukawa N; Araki E
    Nihon Rinsho; 2013 Feb; 71(2):270-4. PubMed ID: 23631205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity, type 2 diabetes and risk of digestive cancer.
    Hillon P; Guiu B; Vincent J; Petit JM
    Gastroenterol Clin Biol; 2010 Oct; 34(10):529-33. PubMed ID: 20864282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipokines, ghrelin and obesity-associated insulin resistance in nondiabetic patients with acute coronary syndrome.
    Barazzoni R; Aleksova A; Armellini I; Cattin MR; Zanetti M; Carriere C; Giacca M; Dore F; Guarnieri G; Sinagra G
    Obesity (Silver Spring); 2012 Dec; 20(12):2348-53. PubMed ID: 22653312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.
    Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
    Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs for the treatment of pediatric type 2 diabetes mellitus and related co-morbidities.
    Tabatabaei-Malazy O; Nikfar S; Larijani B; Abdollahi M
    Expert Opin Pharmacother; 2016 Dec; 17(18):2449-2460. PubMed ID: 27819155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of insulin resistance in diabetes.
    Soumaya K
    Adv Exp Med Biol; 2012; 771():240-51. PubMed ID: 23393683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RBP4: a controversial adipokine.
    Kotnik P; Fischer-Posovszky P; Wabitsch M
    Eur J Endocrinol; 2011 Nov; 165(5):703-11. PubMed ID: 21835764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance and obesity in childhood.
    Chiarelli F; Marcovecchio ML
    Eur J Endocrinol; 2008 Dec; 159 Suppl 1():S67-74. PubMed ID: 18805916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of adipokines in complications related to obesity: a review.
    Gnacińska M; Małgorzewicz S; Stojek M; Łysiak-Szydłowska W; Sworczak K
    Adv Med Sci; 2009; 54(2):150-7. PubMed ID: 19875356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in the Relationship between Adipokines and β-cell Failure in Type 2 Diabetes Mellitus.
    Sun Q; Liang XC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):601-606. PubMed ID: 27825421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timed-daily ingestion of whey protein and exercise training reduces visceral adipose tissue mass and improves insulin resistance: the PRISE study.
    Arciero PJ; Baur D; Connelly S; Ormsbee MJ
    J Appl Physiol (1985); 2014 Jul; 117(1):1-10. PubMed ID: 24833780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study.
    Díaz-Soto G; de Luis DA; Conde-Vicente R; Izaola-Jauregui O; Ramos C; Romero E
    Diabetes Res Clin Pract; 2014 Apr; 104(1):92-6. PubMed ID: 24530118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammation-mediated obesity and insulin resistance as targets for nutraceuticals.
    Kim MS; Lee MS; Kown DY
    Ann N Y Acad Sci; 2011 Jul; 1229():140-6. PubMed ID: 21793849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance: an adaptation for weight maintenance.
    Eckel RH
    Lancet; 1992 Dec; 340(8833):1452-3. PubMed ID: 1360570
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of insulin resistance in non-obese adolescents.
    Baba R; Koketsu M; Nagashima M; Tamakoshi A; Inasaka H
    Nagoya J Med Sci; 2010 Aug; 72(3-4):161-6. PubMed ID: 20942271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tipping the balance: the pathophysiology of obesity and type 2 diabetes mellitus.
    McKenney RL; Short DK
    Surg Clin North Am; 2011 Dec; 91(6):1139-48, vii. PubMed ID: 22054144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body mass index and the risk of Parkinson disease.
    Ikeda K; Kashihara H; Tamura M; Kano O; Iwamoto K; Iwasaki Y
    Neurology; 2007 Jun; 68(24):2156; author reply 2156-7. PubMed ID: 17562841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.